NEOMYCIN B (cas 119-04-0)-cyclen conjugates and their Zn(II) complexes as RNA-binding agents☆
-
Add time:08/26/2019 Source:sciencedirect.com
Three new conjugates featuring the aminoglycoside antibiotic neomycin B linked to the 1,4,7,10-tetraazacyclododecane (cyclen) macrocycle via alkyl chains of varying lengths were synthesized from suitably protected derivatives of these precursors via conventional peptide coupling protocols. The final products were characterized by 1H NMR spectroscopy, mass spectrometry, and elemental analysis. FRET-based measurements examining the ability of the compounds to displace coumarin-labelled kanamycin A or neomycin B from Dy547-labelled prokaryotic ribosomal A-site RNA revealed that they bind to the A-site with slightly higher affinities than the parent aminoglycoside (e.g., IC50 at pH 7 = 1.42–2.30 μM vs. 2.35 μM for neomycin B). This is attributed to the higher overall positive charge of the conjugates, resulting from protonation of the macrocylic amines. Consistent with a predominantly electrostatic mode of interaction, the binding affinities of the conjugates were found to increase with decreasing pH, reflecting a greater degree of protonation at lower pH. The zinc(II) complexes of the neomycin B-cyclen conjugates were found to bind to A-site RNA with even higher affinities (IC50 = 0.85–1.32 μM), due to the Zn(II)-cyclen motif forming coordinative (and/or electrostatic) interactions with the uracil bases and/or phosphate groups within the A-site. These results highlight the potential for the nucleic acid-binding properties of aminoglycosides to be tuned via the covalent attachment of metal complexes, which could ultimately prove useful to the development of new anti-bacterial and anti-viral agents.
We also recommend Trading Suppliers and Manufacturers of NEOMYCIN B (cas 119-04-0). Pls Click Website Link as below: cas 119-04-0 suppliers
Prev:Regular paperChemical modification of spinach plastocyanin using 4-Chloro-3,5-dinitrobenzoic acid (cas 118-97-8): Characterization of four singly-modified forms
Next:Original articlePRISM study: Comparison of a nystatin-neomycin-polymyxin B combination with miconazole for the empirical treatment of infectious vaginitisÉtude PRISM : comparaison de l’association nystatine-néomycine-polymyxine B versus miconazole dans le traitement probabiliste de la vaginite infectieuse☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Identification of NEOMYCIN B (cas 119-04-0)-binding site in T box antiterminator model RNA09/04/2019
- Efficient synthesis of NEOMYCIN B (cas 119-04-0) related aminoglycosides09/03/2019
- Integrated nanotechnology of synergism-sterilization and removing-residues for neomycin through nano-Cu2O09/02/2019
- SPR sensing of small molecules with modified RNA aptamers: Detection of NEOMYCIN B (cas 119-04-0)09/01/2019
- Paromomycin and NEOMYCIN B (cas 119-04-0) derived cationic lipids: Synthesis and transfection studies08/31/2019
- Synthesis and antibacterial activity of amphiphilic lysine-ligated NEOMYCIN B (cas 119-04-0) conjugates08/30/2019
- Quantification of neomycin in rubella vaccine by off/on metal ion mediated photoluminescence from functionalized graphene quantum dots08/29/2019
- Neomycin-dependent hammerhead ribozymes for the direct control of gene expression in Saccharomyces cerevisiae08/28/2019
- Original articlePRISM study: Comparison of a nystatin-neomycin-polymyxin B combination with miconazole for the empirical treatment of infectious vaginitisÉtude PRISM : comparaison de l’association nystatine-néomycine-polymyxine B versus miconazole dans le traitement probabiliste de la vaginite infectieuse☆08/27/2019
-
Health and Chemical more >


